Table 3.

Comparison of the eGFR and prevalence of CKD in subjects with and without NAFLD in the subgroup analyses after propensity score matching.

	NAFLD Status	Number of Patients	eGFR	p-Value	CKD	p-Value
Age < 60 years	Non-NAFLD	816	74.9 ± 11.9	0.394	74 (9.1)	0.315
	NAFLD	825	74.3 ± 12.6		87 (10.5)
Age ≥60 years	Non-NAFLD	281	69.3 ± 11.3	0.531	53 (18.9)	0.973
	NAFLD	272	69.9 ± 12.0		51 (18.8)
Male sex	Non-NAFLD	714	72.6 ± 12.0	0.125	98 (13.7)	0.838
	NAFLD	702	71.7 ± 11.2		99 (14.1)
Female sex	Non-NAFLD	383	75.1 ± 12.0	0.254	29 (7.6)	0.256
	NAFLD	395	76.2 ± 14.3		39 (9.9)
Non-obesity	Non-NAFLD	922	73.9 ± 11.9	0.774	97 (10.5)	0.266
	NAFLD	507	73.7 ± 11.6		44 (8.7)
Obesity	Non-NAFLD	175	71.2 ± 12.7	0.147	30 (17.1)	0.703
	NAFLD	590	72.8 ± 13.2		94 (15.9)
Non-hypertension	Non-NAFLD	776	75.0 ± 11.6	0.655	64 (8.2)	0.554
	NAFLD	691	75.0 ± 12.2		63 (9.1)
Hypertension	Non-NAFLD	321	69.9 ± 12.4	0.282	63 (19.6)	0.694
	NAFLD	406	70.9 ± 12.9		75 (18.5)
Normal triglyceride level	Non-NAFLD	990	73.8 ± 12.1	0.373	110 (11.1)	0.541
	NAFLD	721	73.3 ± 12.3		87 (12.1)
High triglyceride level	Non-NAFLD	107	70.7 ± 11.1	0.038	17 (15.9)	0.542
	NAFLD	376	73.4 ± 13.3		51 (13.6)
Normal LDL cholesterol level	Non-NAFLD	779	73.9 ± 12.4	0.034	92 (11.8)	0.147
	NAFLD	631	72.5 ± 12.5		91 (14.4)
High LDL cholesterol level	Non-NAFLD	318	72.5 ± 10.9	0.025	35 (11.0)	0.679
	NAFLD	466	74.4 ± 12.6		47 (10.1)
Non-diabetes	Non-NAFLD	1308	73.4 ± 11.8	0.886	117 (11.3)	0.519
	NAFLD	984	73.4 ± 12.6		120 (12.2)
Diabetes	Non-NAFLD	59	74.3 ± 15.0	0.473	10 (16.9)	0.863
	NAFLD	113	72.8 ± 13.1		18 (15.9)
Non-hyperuricemia	Non-NAFLD	1012	74.1 ± 11.8	0.474	99 (9.8)	0.725
	NAFLD	906	74.5 ± 12.6		93 (10.3)
Hyperuricemia	Non-NAFLD	85	65.9 ± 12.2	0.283	28 (32.9)	0.103
	NAFLD	191	67.5 ± 11.0		45 (23.6)

Values are expressed as the mean ± standard deviation or number (%). eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease; LDL, low-density lipoprotein; NAFLD, non-alcoholic fatty liver disease.